Want to see IN:MEDICO full AI Analyst Report?
Medico Remedies Ltd. (MEDICO) Ratios
Medico Remedies Ltd. Ratios
IN:MEDICO's free cash flow for Q1 2027 was $0.00. For the 2027 fiscal year, IN:MEDICO's free cash flow was increased by $0.00 and operating cash flow was $0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.66 | 1.70 | 1.72 | 1.55 | 1.51 |
| Quick Ratio | 1.27 | 1.23 | 1.34 | 1.07 | 1.03 |
| Cash Ratio | 0.02 | 0.02 | 0.00 | 0.02 | 0.03 |
| Solvency Ratio | 0.21 | 0.23 | 0.32 | 0.23 | 0.18 |
| Operating Cash Flow Ratio | 0.01 | 0.09 | 0.06 | 0.20 | 0.04 |
| Short-Term Operating Cash Flow Coverage | 0.05 | 0.35 | 0.40 | 1.01 | 0.18 |
| Net Current Asset Value | $ 509.89M | $ 393.45M | $ 299.40M | $ 209.34M | $ 187.03M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.13 | 0.12 | 0.08 | 0.11 | 0.17 |
| Debt-to-Equity Ratio | 0.25 | 0.24 | 0.15 | 0.22 | 0.34 |
| Debt-to-Capital Ratio | 0.20 | 0.19 | 0.13 | 0.18 | 0.25 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 |
| Financial Leverage Ratio | 2.03 | 1.92 | 1.84 | 1.99 | 2.04 |
| Debt Service Coverage Ratio | 0.87 | 0.77 | 1.94 | 1.21 | 0.74 |
| Interest Coverage Ratio | 7.71 | 31.36 | 12.34 | 9.35 | 8.25 |
| Debt to Market Cap | 0.07 | 0.03 | 0.02 | 0.01 | 0.05 |
| Interest Debt Per Share | 2.53 | 1.92 | 1.07 | 1.27 | 1.59 |
| Net Debt to EBITDA | 0.75 | 0.91 | 0.44 | 0.65 | 1.22 |
| Profitability Margins | |||||
| Gross Profit Margin | 21.59% | 28.23% | 12.09% | 25.33% | 14.60% |
| EBIT Margin | 9.63% | 7.93% | 8.26% | 7.72% | 5.88% |
| EBITDA Margin | 11.13% | 9.94% | 12.24% | 9.66% | 7.71% |
| Operating Profit Margin | 6.75% | 24.07% | 7.01% | 4.97% | 4.31% |
| Pretax Profit Margin | 8.75% | 8.95% | 7.82% | 7.19% | 5.36% |
| Net Profit Margin | 6.35% | 6.69% | 5.72% | 5.16% | 3.98% |
| Continuous Operations Profit Margin | 6.35% | 6.69% | 5.72% | 5.16% | 3.98% |
| Net Income Per EBT | 72.62% | 74.74% | 73.14% | 71.71% | 74.22% |
| EBT Per EBIT | 129.62% | 37.16% | 111.50% | 144.60% | 124.30% |
| Return on Assets (ROA) | 8.55% | 8.43% | 8.62% | 8.28% | 6.32% |
| Return on Equity (ROE) | 17.38% | 16.16% | 15.83% | 16.52% | 12.89% |
| Return on Capital Employed (ROCE) | 18.39% | 57.82% | 19.04% | 15.29% | 13.71% |
| Return on Invested Capital (ROIC) | 10.69% | 35.19% | 12.28% | 9.25% | 8.22% |
| Return on Tangible Assets | 8.55% | 8.43% | 8.63% | 8.29% | 6.32% |
| Earnings Yield | 4.82% | 2.29% | 2.02% | 1.16% | 2.39% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.52 | 2.64 | 2.92 | 3.89 | 3.95 |
| Payables Turnover | 3.28 | 3.12 | 4.04 | 3.38 | 3.53 |
| Inventory Turnover | 5.39 | 4.05 | 7.80 | 5.32 | 5.29 |
| Fixed Asset Turnover | 8.99 | 6.99 | 6.78 | 6.43 | 7.52 |
| Asset Turnover | 1.35 | 1.26 | 1.51 | 1.61 | 1.59 |
| Working Capital Turnover Ratio | 4.54 | 4.27 | 5.40 | 6.66 | 6.05 |
| Cash Conversion Cycle | 101.45 | 111.36 | 81.53 | 54.53 | 58.20 |
| Days of Sales Outstanding | 145.01 | 138.27 | 125.01 | 93.81 | 92.47 |
| Days of Inventory Outstanding | 67.70 | 90.05 | 46.81 | 68.56 | 69.06 |
| Days of Payables Outstanding | 111.26 | 116.96 | 90.28 | 107.84 | 103.33 |
| Operating Cycle | 212.72 | 228.32 | 171.81 | 162.37 | 161.53 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.12 | 0.59 | 0.32 | 0.98 | 0.21 |
| Free Cash Flow Per Share | -0.42 | 0.21 | 0.02 | 0.19 | -0.14 |
| Dividend Paid and CapEx Coverage Ratio | 0.22 | 1.54 | 1.08 | 1.24 | 0.60 |
| Capital Expenditure Coverage Ratio | 0.22 | 1.54 | 1.08 | 1.24 | 0.60 |
| Operating Cash Flow Coverage Ratio | 0.05 | 0.33 | 0.33 | 0.84 | 0.14 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.03 | 0.02 | 0.06 | 0.01 |
| Free Cash Flow Yield | -1.28% | 0.39% | 0.05% | 0.25% | -0.57% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 20.73 | 43.69 | 49.45 | 86.00 | 41.85 |
| Price-to-Sales (P/S) Ratio | 1.32 | 2.92 | 2.83 | 4.43 | 1.66 |
| Price-to-Book (P/B) Ratio | 3.60 | 7.06 | 7.83 | 14.21 | 5.40 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -78.06 | 258.26 | 2005.80 | 395.45 | -175.10 |
| Price-to-Operating Cash Flow Ratio | 270.26 | 90.14 | 152.83 | 76.26 | 117.76 |
| Price-to-Earnings Growth (PEG) Ratio | 0.70 | 1.99 | 3.31 | 1.72 | 0.48 |
| Enterprise Value Multiple | 12.60 | 30.30 | 23.56 | 46.56 | 22.80 |
| Enterprise Value | 2.89B | 4.55B | 4.18B | 6.32B | 2.13B |
| EV to EBITDA | 12.60 | 30.30 | 23.56 | 46.56 | 22.80 |
| EV to Sales | 1.40 | 3.01 | 2.88 | 4.50 | 1.76 |
| EV to Free Cash Flow | -83.03 | 266.23 | 2044.29 | 401.07 | -185.04 |
| EV to Operating Cash Flow | 287.45 | 92.92 | 155.76 | 77.34 | 124.44 |
| Tangible Book Value Per Share | 9.09 | 7.54 | 6.30 | 5.27 | 4.49 |
| Shareholders’ Equity Per Share | 9.09 | 7.55 | 6.32 | 5.28 | 4.49 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.27 | 0.25 | 0.27 | 0.28 | 0.26 |
| Revenue Per Share | 24.86 | 18.24 | 17.48 | 16.92 | 14.54 |
| Net Income Per Share | 1.58 | 1.22 | 1.00 | 0.87 | 0.58 |
| Tax Burden | 0.73 | 0.75 | 0.73 | 0.72 | 0.74 |
| Interest Burden | 0.91 | 1.13 | 0.95 | 0.93 | 0.91 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.15 | 0.07 | 0.04 | 0.02 | 0.02 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.08 | 0.48 | 0.32 | 1.13 | 0.35 |
Currency in INR
